MHMaite M. T. van Haeren

Maite M. T. van Haeren

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maite M. T. van Haeren has a total of 66 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effect of Bicuspid or Tricuspid Aortic Valve on Preoperative Coagulation in Patients Scheduled for Thoracic Aortic Surgery

    by Maite M.T. van Haeren, Caitlin Bozic, Susanne Eberl, Markus W. Hollmann, Jennifer S. Breel, Nimrat Grewal, Antoine H.G. Driessen, Alexander P.J. Vlaar, Marcella C.A. Müller, Henning Hermanns

  • Open Access

    Pre‐operative reference ranges for ROTEM ® sigma in patients undergoing cardiac surgery: a secondary analysis of two prospective trial cohorts

    by Maite M. T. van Haeren, Meike Brouwers, Jimmy Schenk, Jennifer S. Breel, Sijm H. Noteboom, Eline Kho, Susanne Eberl, Denise P. Veelo, Alexander P. J. Vlaar, Marcella C. A. Müller, et al.

    Summary: Introduction: Rotational thromboelastometry (ROTEM ® ) is used widely in cardiac surgery. Reference ranges are derived from healthy volunteers but may not be interchangeable with those from patients undergoing cardiac surgery. Furthermore, sex and age seem to influence rotational thromboelastometry profiles. We performed a secondary analysis of two prospective observational study cohorts from a single centre in the Netherlands, which establishes pre‐operative ROTEM ® sigma reference ranges for adult patients undergoing cardiac surgery and examines sex‐ and age‐specific variations. Methods: Reference ranges (2.5–97.5th percentiles) were compared with those reported by the manufacturer by calculating 95% CIs around the percentiles. Sex‐ and age‐specific variations were evaluated similarly by creating subgroups (comparing males with females and different age groups) and calculating the 95% CIs for the ranges in each subgroup. Non‐overlapping CIs indicated statistically significant different ranges. Results: We included 381 patients in the analysis. Differences were found in ROTEM sigma reference ranges compared with those stated by the manufacturer: EXTEM and FIBTEM clot firmness upper limits were higher, and clotting time ranges in EXTEM and INTEM were wider. The lower limit of LI60 EXTEM was lower. When comparing males (n = 260) and females (n = 121), female patients had shorter CT EXTEM and higher A5, A10 and MCF in EXTEM and FIBTEM, but the reference ranges were not significantly different. No differences in medians or reference bounds were found across four age categories, divided by quartiles. Discussion: Reference ranges for patients undergoing cardiac surgery differed from the manufacturer reference ranges. Pre‐operatively, female patients exhibited a slightly more hypercoagulable ROTEM profile than males when comparing medians, though the reference ranges were similar. No differences were found across age categories. Cardiovascular‐specific, but not sex‐ or age‐specific ROTEM sigma reference ranges might be needed.


  • Open Access

    Plasma transfusion in the intensive care unit

    by Maite M. T. van Haeren, Senta Jorinde Raasveld, Sanne de Bruin, Merijn C. Reuland, Claudia van Den Oord, Jimmy Schenk, Cécile Aubron, Jan Bakker, Maurizio Cecconi, Aarne Feldheiser, et al.

    Background: Current guidelines discourage prophylactic plasma use in non‐bleeding patients. This study assesses global plasma transfusion practices in the intensive care unit (ICU) and their alignment with current guidelines.Study Design and Methods: This was a sub‐study of an international, prospective, observational cohort. Primary outcomes were in‐ICU occurrence rate of plasma transfusion, proportion of plasma events of total blood products events, and number of plasma units per event. Secondary outcomes included transfusion indications, INR/PT, and proportion of events for non‐bleeding indications.Results: Of 3643 patients included, 356 patients (10%) experienced 547 plasma transfusion events, accounting for 18% of total transfusion events. A median of 2 (IQR 1, 2) units was given per event excluding massive transfusion protocol (MTP) and 3 (IQR 2, 6) when MTP was activated. MTP accounted for 39 (7%) of events. Indications of non‐MTP events included active bleeding (54%), prophylactic (25%), and pre‐procedure (12%). Target INR/PT was stated for 43% of transfusion events; pre‐transfusion INR/PT or visco‐elastic hemostatic assays (VHA) were reported for 73%. Thirty‐seven percent of events were administered for non‐bleeding indications, 54% with a pre‐transfusion INR < 3.0 and 30% with an INR < 1.5.Discussion: Plasma transfusions occurred in 10% of ICU patients. Over a third were given for non‐bleeding indications and might have been avoidable. Target INR/PT was not stated in more than half of transfusions, and pre‐transfusion INR/PT or VHA was not reported for 27%. Further research and education is needed to optimize guideline implementation and to identify appropriate indications for plasma transfusion.


  • Open Access

    Comparison of ROTEM® Delta and ROTEM® Sigma transfusion algorithm performance in thoracic aortic surgery: a single-centre prospective observational cohort study

    by Maite M.T. van Haeren, Jenni S. Breel, Jimmy Schenk, Susanne Eberl, Henrike M. Hamer, Markus W. Hollmann, Alexander P.J. Vlaar, Marcella C.A. Müller, Henning Hermanns, Michael Meesters, et al.